Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung

[1] Skowronski DM(2009)Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006–2007 J Infect Dis 199 168-179

[2] De Serres G(2001)Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children Philos Trans R Soc Lond B Biol Sci 356 1947-1951

[3] Dickinson J(2004)Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000–2001 influenza A(H1N1) and B epidemic in healthy children Arch Pediatr Adolesc Med 158 65-73

[4] Petric M(2013)The avian and mammalian host range of highly pathogenic avian H5N1 influenza Virus Res 178 3-11

[5] Mak A(2014)Preliminary success in the characterization and management of a sudden breakout of a novel H7N9 influenza A virus Int J Biol Sci 10 109-118

[6] Fonseca K(2012)Swine flu is back again: a review Pak J Biol Sci 15 1001-1009

[7] Kwindt TL(2001)Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection J Immunother 24 172-183

[8] Chan T(2006)Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835] Breast Cancer Res 8 R27-877

[9] Bastien N(2006)Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma Clin Cancer Res 12 869-1078

[10] Charest H(2002)Oxidised mannan as a novel adjuvant inducing mucosal IgA production Vaccine 20 1068-436

[1] Skowronski DM(2009)Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006–2007 J Infect Dis 199 168-179

[2] De Serres G(2001)Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children Philos Trans R Soc Lond B Biol Sci 356 1947-1951

[3] Dickinson J(2004)Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000–2001 influenza A(H1N1) and B epidemic in healthy children Arch Pediatr Adolesc Med 158 65-73

[4] Petric M(2013)The avian and mammalian host range of highly pathogenic avian H5N1 influenza Virus Res 178 3-11

[5] Mak A(2014)Preliminary success in the characterization and management of a sudden breakout of a novel H7N9 influenza A virus Int J Biol Sci 10 109-118

[6] Fonseca K(2012)Swine flu is back again: a review Pak J Biol Sci 15 1001-1009

[7] Kwindt TL(2001)Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection J Immunother 24 172-183

[8] Chan T(2006)Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835] Breast Cancer Res 8 R27-877

[9] Bastien N(2006)Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma Clin Cancer Res 12 869-1078

[10] Charest H(2002)Oxidised mannan as a novel adjuvant inducing mucosal IgA production Vaccine 20 1068-436